iBio logo

iBio (IBIO) Q2 2024 Annual Earnings

IBIO·Reported September 25, 2024·Before market open

iBio reported Q2 2024 revenue of $175.0K. Diluted EPS came in at $-0.91, missed the $-0.47 consensus by $0.44.

Revenue
$175.0K
Diluted EPS
$-0.91missed by $0.44
Consensus: $-0.47
SEC

SEC Filings

Earnings release8-K not filed yet
Annual report10-K · 0001420720-24-000038

Financial Snapshot

Trailing eight quarters through Q2 2024

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q2 2024 Earnings FAQ

Common questions about iBio's Q2 2024 earnings report.

iBio (IBIO) reported Q2 2024 earnings on September 25, 2024 before market open.

iBio reported revenue of $175.0K and diluted EPS of $-0.91 for Q2 2024.

EPS missed the consensus estimate of $-0.47 by $0.44.

You can read the 10-K periodic report (0001420720-24-000038) directly on SEC EDGAR. The filing index links above go to sec.gov.